Entrada Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KEntrada Therapeutics, Inc.TRDA5d

   Entrada Therapeutics reports positive Cohort 1 results

   • Cohort 1 of ELEVATE-45-201 showed 0.10% mean increase in dystrophin
   • No serious adverse events reported, all participants moved to Phase 2
   • Plasma exposures matched juvenile NHP data predictions
2. NOTABLESCHEDULE 13D/AEntrada Therapeutics, Inc.TRDASep 10

   Ownership stake disclosure by MPM BioVentures 2014, L.P. (amended)

   MPM BioVentures 2014, L.P., filed by

3. ROUTINE4Entrada Therapeutics, Inc.TRDASep 9

   2 insider filings

   MPM BIOVENTURES 2018, L.P., insider filing for TRDA

   Show all 2

   • 4Insider filing for TRDASep 9
   • 4Insider filing for TRDASep 9

   MPM BIOVENTURES 2018, L.P., reporting · MPM BioVentures 2018 GP LLC, reporting · +1 more

4. ROUTINE4Entrada Therapeutics, Inc.TRDASep 3

   2 insider filings

   MPM BIOVENTURES 2018, L.P., insider filing for TRDA

   Show all 2

   • 4Insider filing for TRDASep 3
   • 4Insider filing for TRDASep 3

   MPM BIOVENTURES 2018, L.P., reporting · MPM BioVentures 2018 GP LLC, reporting · +1 more

5. ROUTINE4Entrada Therapeutics, Inc.TRDASep 3

   4 insider filings

   Dipal Doshi, insider filing for TRDA

   Show all 4

   • 4Insider filing for TRDASep 3
   • 4Insider filing for TRDASep 3
   • 4Insider filing for TRDASep 3
   • 4Insider filing for TRDASep 3

   Dipal Doshi, reporting

6. ROUTINE4Entrada Therapeutics, Inc.TRDAAug 31

   2 insider filings

   MPM BIOVENTURES 2018, L.P., insider filing for TRDA

   Show all 2

   • 4Insider filing for TRDAAug 31
   • 4Insider filing for TRDAAug 31

   MPM BIOVENTURES 2018, L.P., reporting · MPM BioVentures 2018 GP LLC, reporting · +1 more

7. ROUTINE4Entrada Therapeutics, Inc.TRDAAug 26

   2 insider filings

   Ansbert Gadicke, insider filing for TRDA

   Show all 2

   • 4Insider filing for TRDAAug 26
   • 4Insider filing for TRDAAug 26

   Ansbert Gadicke, reporting · Luke Evnin, reporting · +8 more

8. ROUTINESCHEDULE 13G/AEntrada Therapeutics, Inc.TRDAAug 14

   Ownership stake disclosure by TCG Crossover GP I, LLC (amended)

   TCG Crossover GP I, LLC, filed by

9. ROUTINE4Entrada Therapeutics, Inc.TRDAAug 10

   2 insider filings

   Kush Parmar, insider filing for TRDA

   Show all 2

   • 4Insider filing for TRDAAug 10
   • 4Insider filing for TRDAAug 10

   Kush Parmar, reporting

10. ROUTINE144/AEntrada Therapeutics, Inc.TRDAAug 10

    5AM Ventures V, L.P., planned sale of TRDA shares (amended)

    5AM Ventures V, L.P., reporting

11. NOTABLE10-QEntrada Therapeutics, Inc.TRDAAug 5

    Quarterly report

12. ROUTINE8-KEntrada Therapeutics, Inc.TRDAAug 5

    Current report

13. ROUTINE4Entrada Therapeutics, Inc.TRDAAug 3

    2 insider filings

    Scott M Rocklage, insider filing for TRDA

    Show all 2

    • 4Insider filing for TRDAAug 3
    • 4Insider filing for TRDAAug 3

    Scott M Rocklage, reporting · Andrew J. Schwab, reporting · +4 more

14. ROUTINE144Entrada Therapeutics, Inc.TRDAJul 30

    5AM Ventures V, L.P., planned sale of TRDA shares

    5AM Ventures V, L.P., reporting

15. ROUTINE4Entrada Therapeutics, Inc.TRDAJun 12

    6 insider filings

    Kush Parmar, insider filing for TRDA

    Show all 6

    • 4Insider filing for TRDAJun 12
    • 4Insider filing for TRDAJun 12
    • 4Insider filing for TRDAJun 12
    • 4Insider filing for TRDAJun 12
    • 4Insider filing for TRDAJun 12
    • 4Insider filing for TRDAJun 12

    Kush Parmar, reporting

16. ROUTINE8-KEntrada Therapeutics, Inc.TRDAJun 10

    Current report

17. ROUTINE4Entrada Therapeutics, Inc.TRDAMay 21

    Bernhardt G Zeiher, insider filing for TRDA

    Bernhardt G Zeiher, reporting

18. NOTABLE10-QEntrada Therapeutics, Inc.TRDAMay 7

    Quarterly report

19. ROUTINE8-KEntrada Therapeutics, Inc.TRDAMay 7

    Current report

20. ROUTINE4Entrada Therapeutics, Inc.TRDAMay 4

    2 insider filings

    Natarajan Sethuraman, insider filing for TRDA

    Show all 2

    • 4Insider filing for TRDAMay 4
    • 4Insider filing for TRDAMay 4

    Natarajan Sethuraman, reporting

21. ROUTINE144Entrada Therapeutics, Inc.TRDAMay 4

    2 Form 144 notices

    Nathan J Dowden, planned sale of TRDA shares

    Show all 2

    • 144Planned insider sale of TRDA sharesMay 4
    • 144Planned insider sale of TRDA sharesMay 4

    Nathan J Dowden, reporting

22. ROUTINEDEFA14AEntrada Therapeutics, Inc.TRDAApr 29

    Additional proxy materials

23. ROUTINEARSEntrada Therapeutics, Inc.TRDAApr 24

    Annual report to shareholders

24. ROUTINEDEFA14AEntrada Therapeutics, Inc.TRDAApr 24

    Additional proxy materials

25. ROUTINEDEF 14AEntrada Therapeutics, Inc.TRDAApr 24

    Proxy statement

26. ROUTINE4Entrada Therapeutics, Inc.TRDAApr 2

    Kory James Wentworth, insider filing for TRDA

    Kory James Wentworth, reporting

27. ROUTINE144Entrada Therapeutics, Inc.TRDAApr 1

    Kory James Wentworth, planned sale of TRDA shares

    Kory James Wentworth, reporting

28. ROUTINE4Entrada Therapeutics, Inc.TRDAMar 11

    2 insider filings

    Nathan J Dowden, insider filing for TRDA

    Show all 2

    • 4Insider filing for TRDAMar 11
    • 4Insider filing for TRDAMar 11

    Nathan J Dowden, reporting

29. ROUTINE144Entrada Therapeutics, Inc.TRDAMar 9

    2 Form 144 notices

    Kory James Wentworth, planned sale of TRDA shares

    Show all 2

    • 144Planned insider sale of TRDA sharesMar 9
    • 144Planned insider sale of TRDA sharesMar 9

    Kory James Wentworth, reporting

30. ROUTINE4Entrada Therapeutics, Inc.TRDAMar 6

    Kory James Wentworth, insider filing for TRDA

    Kory James Wentworth, reporting

31. ROUTINE144Entrada Therapeutics, Inc.TRDAMar 4

    Kory James Wentworth, planned sale of TRDA shares

    Kory James Wentworth, reporting

32. ROUTINE4Entrada Therapeutics, Inc.TRDAMar 3

    Dipal Doshi, insider filing for TRDA

    Dipal Doshi, reporting

Older filings on EDGAR